title: Influence of diabetes mellitus on vertebral fractures in men with acromegaly.
abstract: Acromegaly is frequently complicated by fragility vertebral fractures and diabetes mellitus. Since type 2 diabetes mellitus is a cause of secondary osteoporosis in the general population, in this cross-sectional study we aimed at investigating the association between diabetes mellitus and vertebral fractures in males with acromegaly. Fifty-seven patients (median age 47 years, range: 24-85) with active (21 cases) and controlled (36 cases) acromegaly and 57 control subjects were evaluated for bone mineral density (BMD) by DXA and vertebral fractures by a quantitative morphometric analysis. Diabetes mellitus was found in 18 patients and 18 control subjects. The prevalence of vertebral fractures was higher in acromegalic patients as compared with the control subjects (50.9 vs. 10.5%; χ(2): 21.8; P < 0.001). Acromegalic patients with fractures had serum IGF-I values significantly higher (P = 0.009), longer duration of active disease (P < 0.001) and higher prevalence of active acromegaly (P = 0.007) and diabetes mellitus (P = 0.04) as compared to patients who did not fracture. When acromegaly was active, the prevalence of vertebral fractures was high independently of the coexistent diabetes mellitus. On the contrary, when acromegaly was controlled the prevalence of vertebral fractures was significantly higher in patients with diabetes as compared to patients without diabetes (62.6 vs. 28.0%; P = 0.04). In both diabetic and non diabetic patients, vertebral fractures occurred independently of BMD. In conclusion, this study suggests that diabetes mellitus may be associated with an increased prevalence of vertebral fractures in males with acromegaly. However, this effect seems to be relatively attenuated in the presence of persistent GH hypersecretion.
authors: Department of Medical and Surgical Sciences University of Brescia, Endocrine Service, Montichiari Hospital, Brescia, Italy.
authors: Gherardo
authors: G
authors: Mazziotti
authors: Monica
authors: M
authors: Gola
authors: Antonio
authors: A
authors: Bianchi
authors: Teresa
authors: T
authors: Porcelli
authors: Antonella
authors: A
authors: Giampietro
authors: Vincenzo
authors: V
authors: Cimino
authors: Mauro
authors: M
authors: Doga
authors: Carmine
authors: C
authors: Gazzaruso
authors: Laura
authors: L
authors: De Marinis
authors: Andrea
authors: A
authors: Giustina
references: Clin Endocrinol (Oxf). 2009 Mar;70(3):378-82
references: 18616713
references: Endocr Rev. 2008 Aug;29(5):535-59
references: 18436706
references: J Clin Endocrinol Metab. 2008 Dec;93(12):4649-55
references: 18827004
references: Diabetes Care. 2011 Jan;34 Suppl 1:S62-9
references: 21193628
references: Neuroendocrinology. 2008;88(4):299-304
references: 18617732
references: Endocrine. 2009 Jun;35(3):371-9
references: 19288226
references: Age Ageing. 2008 Mar;37(2):222-5
references: 18033779
references: Cell. 2010 Jul 23;142(2):198-200
references: 20655463
references: J Bone Miner Res. 2003 Jul;18(7):1254-60
references: 12854835
references: Clin Endocrinol (Oxf). 1998 Jan;48(1):59-65
references: 9509069
references: Ann Rheum Dis. 2011 Feb;70(2):320-5
references: 21131647
references: J Clin Endocrinol Metab. 1999 Oct;84(10):3666-72
references: 10523012
references: Eur J Endocrinol. 2011 Apr;164(4):475-83
references: 21257726
references: Endocrine. 2004 Mar-Apr;23(2-3):183-8
references: 15146099
references: J Clin Endocrinol Metab. 2009 Oct;94(10):3889-96
references: 19723758
references: J Bone Miner Res. 2006 Apr;21(4):520-8
references: 16598371
references: Diabetes Metab. 2008 Jun;34(3):193-205
references: 18308607
references: Ann Intern Med. 1998 May 15;128(10):793-800
references: 9599190
references: Endocr Rev. 2004 Feb;25(1):102-52
references: 14769829
references: Cell. 2007 Aug 10;130(3):456-69
references: 17693256
references: J Endocrinol Invest. 2003 Dec;26(12):1242-7
references: 15055479
references: J Bone Miner Res. 1996 Jul;11(7):984-96
references: 8797120
references: Eur J Endocrinol. 2009 Feb;160(2):265-73
references: 18996964
references: Endocr Rev. 2010 Jun;31(3):301-42
references: 20086217
references: J Bone Miner Res. 2005 Oct;20(10):1837-44
references: 16160741
references: J Clin Endocrinol Metab. 2009 May;94(5):1500-8
references: 19208728
references: Endocrine. 2011 Jun;39(3):288-93
references: 21479837
references: Pituitary. 2008;11(1):55-61
references: 17965964
references: Bone. 2009 Oct;45(4):784-8
references: 19527806
references: Clin Endocrinol (Oxf). 2003 Jun;58(6):725-31
references: 12780749
references: Eur J Clin Invest. 2002 Feb;32(2):122-8
references: 11895459
references: J Clin Endocrinol Metab. 1993 Jun;76(6):1452-7
references: 8501150
references: Osteoporos Int. 2007 Apr;18(4):427-44
references: 17068657
references: J Clin Endocrinol Metab. 2010 Jul;95(7):3141-8
references: 20410227
references: Am J Med. 2010 Oct;123(10):877-84
references: 20920685
references: Clin Endocrinol (Oxf). 2001 Feb;54(2):189-95
references: 11207633
references: J Clin Endocrinol Metab. 2000 Feb;85(2):526-9
references: 10690849
references: Endocrine. 2005 Oct;28(1):123-8
references: 16311419
references: J Bone Miner Res. 2011 Apr;26(4):677-80
references: 21433069
references: J Clin Endocrinol Metab. 2009 May;94(5):1509-17
references: 19208732